Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.

Thompson MD, Dar MJ, Monga SP.

J Hepatol. 2011 Mar;54(3):506-12. doi: 10.1016/j.jhep.2010.07.020. Epub 2010 Oct 29.

2.

RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1.

Hendriksen J, Fagotto F, van der Velde H, van Schie M, Noordermeer J, Fornerod M.

J Cell Biol. 2005 Dec 5;171(5):785-97. Epub 2005 Nov 28.

3.

Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?

Ceballos MP, Parody JP, Alvarez Mde L, Ingaramo PI, Carnovale CE, Carrillo MC.

Biochem Pharmacol. 2011 Dec 1;82(11):1682-91. doi: 10.1016/j.bcp.2011.08.001. Epub 2011 Aug 6.

PMID:
21843516
4.

Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.

Liu J, Ding X, Tang J, Cao Y, Hu P, Zhou F, Shan X, Cai X, Chen Q, Ling N, Zhang B, Bi Y, Chen K, Ren H, Huang A, He TC, Tang N.

PLoS One. 2011;6(11):e27496. doi: 10.1371/journal.pone.0027496. Epub 2011 Nov 15.

5.

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.

Ma L, Wang X, Jia T, Wei W, Chua MS, So S.

Oncotarget. 2015 Sep 22;6(28):25390-401. doi: 10.18632/oncotarget.4455.

6.

Pegylated interferon-α2a inhibits proliferation of human liver cancer cells in vitro and in vivo.

Kusano H, Akiba J, Ogasawara S, Sanada S, Yasumoto M, Nakayama M, Ueda K, Ueda K, Kurita T, Todoroki K, Umeno Y, Nakashima O, Yano H.

PLoS One. 2013 Dec 12;8(12):e83195. doi: 10.1371/journal.pone.0083195. eCollection 2013.

7.

Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.

Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell P, Tsai HW, Barretina J, Thung S, Ward SC, Bruix J, Mazzaferro V, Schwartz M, Friedman SL, Llovet JM.

Clin Cancer Res. 2012 Sep 15;18(18):4997-5007. Epub 2012 Jul 18.

8.

Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.

Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.

Transl Res. 2007 Nov;150(5):281-94. Epub 2007 Jul 18.

PMID:
17964517
9.

Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.

Quan H, Zhou F, Nie D, Chen Q, Cai X, Shan X, Zhou Z, Chen K, Huang A, Li S, Tang N.

Oncogene. 2014 May 29;33(22):2826-35. doi: 10.1038/onc.2013.225. Epub 2013 Jun 17.

PMID:
23770846
10.

Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line.

Liu J, Wang Z, Tang J, Tang R, Shan X, Zhang W, Chen Q, Zhou F, Chen K, Huang A, Tang N.

Arch Virol. 2011 Jun;156(6):1013-23. doi: 10.1007/s00705-011-0943-x. Epub 2011 Feb 22.

PMID:
21340743
11.

Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.

Fatima S, Lee NP, Tsang FH, Kolligs FT, Ng IO, Poon RT, Fan ST, Luk JM.

Oncogene. 2012 Sep 20;31(38):4233-44. doi: 10.1038/onc.2011.580. Epub 2012 Jan 16.

PMID:
22249261
12.

Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.

Renard CA, Labalette C, Armengol C, Cougot D, Wei Y, Cairo S, Pineau P, Neuveut C, de Reyniès A, Dejean A, Perret C, Buendia MA.

Cancer Res. 2007 Feb 1;67(3):901-10.

13.

Wnt/beta-catenin signaling pathway may regulate cell cycle and expression of cyclin A and cyclin E protein in hepatocellular carcinoma cells.

Wang X, Meng X, Sun X, Liu M, Gao S, Zhao J, Pei F, Yu H.

Cell Cycle. 2009 May 15;8(10):1567-70. Epub 2009 May 19.

PMID:
19411833
14.

PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.

Liu Y, Ye X, Zhang JB, Ouyang H, Shen Z, Wu Y, Wang W, Wu J, Tao S, Yang X, Qiao K, Zhang J, Liu J, Fu Q, Xie Y.

Oncogene. 2015 Oct 29;34(44):5524-35. doi: 10.1038/onc.2015.7. Epub 2015 Feb 16.

PMID:
25684142
15.

Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.

Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD Jr.

Bone. 2008 Apr;42(4):669-80. doi: 10.1016/j.bone.2007.12.006. Epub 2007 Dec 27.

PMID:
18294945
16.

Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.

Arakawa Y, Shimada M, Utsunomiya T, Imura S, Morine Y, Ikemoto T.

J Surg Res. 2012 Jan;172(1):95-101. doi: 10.1016/j.jss.2010.07.023. Epub 2010 Aug 6.

PMID:
20851413
17.

HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.

Chen Z, Tang J, Cai X, Huang Y, Gao Q, Liang L, Tian L, Yang Y, Zheng Y, Hu Y, Tang N.

Cancer Sci. 2016 Oct;107(10):1380-1389. doi: 10.1111/cas.13014. Epub 2016 Sep 1.

18.

Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.

Yano H, Ogasawara S, Momosaki S, Akiba J, Kojiro S, Fukahori S, Ishizaki H, Kuratomi K, Basaki Y, Oie S, Kuwano M, Kojiro M.

Liver Int. 2006 Oct;26(8):964-75.

PMID:
16953837
19.

Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.

Latasa MU, Salis F, Urtasun R, Garcia-Irigoyen O, Elizalde M, Uriarte I, Santamaria M, Feo F, Pascale RM, Prieto J, Berasain C, Avila MA.

PLoS One. 2012;7(12):e52711. doi: 10.1371/journal.pone.0052711. Epub 2012 Dec 20.

20.

Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-beta signaling.

Dai F, Lin X, Chang C, Feng XH.

Dev Cell. 2009 Mar;16(3):345-57. doi: 10.1016/j.devcel.2009.01.022.

Supplemental Content

Support Center